HealthScout Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 
 
 Printer Friendly  Send to a Friend

Molecular Switch in Brain May End Smokers' Cravings

A key receptor cuts the urge for nicotine, rat study suggests


Related Encyclopedia
 border=
Acne
Acoustic Neurinoma
Angina Pectoris
Angiogram
More...

Related Healthscout Videos
 border=
New Drugs That Could Stop MS
Stents for Emphysema
Stents for Emphysema
New Therapy for Stroke Patients
More...

Related Drug Information
 border=
Adderal XR
Concerta
Coumadin
Depakote
More...

Related News Articles
 border=
Family History of Aneurysm Raises Stroke Risk for Smokers
Study of Everest Climbers Questions Oxygen Use
Easing Back Pain With Electricity
How Viagra Protects the Heart
More...

MONDAY, Nov. 24 (HealthDay News) -- Blocking a neuropeptide receptor in the brain may be one way to quickly lessen the desire for a cigarette, a new study suggests.

Hypocretin-1, or Orexin A, a short chain of amino acids found in nerve tissue, appears to initiate a series of closely linked biochemical reactions that makes lab rats crave nicotine, the addictive chemical in tobacco, according to researchers at the Scripps Florida research institute in Jupiter.

Text Continues Below



If duplicated in humans, the finding could be lead to new smoking-cessation treatments, the researchers said.

"Blocking hypocretin-1 receptors not only decreased the motivation to continue nicotine use in rats, it also abolished the stimulatory effects of nicotine on their brain reward circuitries," study leader Paul Kenny, a scientist at Scripps Florida, explained in a news release issued by the institute. "This suggests that hypocretin-1 may play a major role in driving tobacco use in smokers to want more nicotine. If we can find a way to effectively block this receptor, it could mean a novel way to help break people's addiction to tobacco."

In the study, the researchers blocked the hypocretin-1 receptor with low doses of the selective antagonist SB-334867, a commercially available compound often used in research.

The results of the study were published in an online early edition of Proceedings of the National Academy of Sciences, released this week.

The findings might explain why some human smokers spontaneously quit smoking after suffering brain damage in a small area of their frontal cortex. Hypocretin-1 receptors are found in the insula, a walnut-size part of the frontal lobe of the brain, the researchers said.

Previous Scripps research found that hypocretin-1 receptors also play a central role in regulating relapse in cocaine addicts.

Cigarette smoking accounts for about 440,000 deaths and $160 billion in health-related costs annually in the United States. Only about 10 percent of smokers who attempt to quit manage to remain smoke free after one year, the researchers said.

More information

The American Cancer Society has more about quitting smoking.



-- Kevin McKeever

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 11/24/2008

Related Links
 border=
From Healthscout's partner site on asthma, MyAsthmaCentral.com
VIDEO: Lung stents help asthmatics to breathe easier
TREATMENT: Medication and lifestyle changes provide asthma relief
DRUGS: Common drugs used to treat asthma




SOURCE: Scripps Florida, news release, Nov. 24, 2008


Healthscout Search
Health Tools
 Quiz: How Addicted Are You?
 Guide to Living Smoke Free
 Smoking Health Risks
 Video: Targeting Lung Cancer
 Stop Smoking Basics
Resources
Healthscout News
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
Newsletter Subscription
News Archive
PR Newswire News Video Releases
Privacy Policy

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service